Skip to content

Adult Neuronal Ceroid Lipofuscinosis C0022797

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder causing progressive nerve cell damage in adults. It leads to vision loss, cognitive decline, and movement problems. There is no cure; care focuses on managing symptoms and supporting quality of life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Progressive visual loss

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Ataxia

(neurologic)

Myoclonus

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticonvulsant therapy

Anti-epileptic medications are prescribed to control seizure activity, which is common in neuronal ceroid lipofuscinosis. Medication selection considers seizure type and overall neurological status.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Physical therapy

Structured physical therapy programs help maintain motor function, preserve range of motion, and prevent contractures as the disease progresses. Adaptive equipment may be incorporated as needed.

physical_therapy

Additional treatment options

Regular neurological monitoring

Comprehensive neurological assessments track disease progression, guide treatment adjustments, and identify emerging symptoms requiring intervention.

monitoring

Cognitive and behavioral support

Psychological interventions address cognitive decline, behavioral changes, and emotional challenges. Educational support helps families understand and cope with disease progression.

psychological

Nutritional management

Dietary assessment and management address feeding difficulties and weight maintenance. In some cases, modified textures or supplemental nutrition may be required to ensure adequate intake.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Adult Neuronal Ceroid Lipofuscinosis C0022797?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mole SE, Williams RE, Goebel HH. The neuronal ceroid lipofuscinoses (Batten disease). Handb Clin Neurol. 2011;100:139-159.

review2011
2

NCL Foundation Clinical Advisory Board. Consensus Guidelines for Diagnosis and Management of Neuronal Ceroid Lipofuscinoses. Orphanet J Rare Dis. 2020;15(1):78.

guideline2020
3

Kohan R, Pesa S, Dodelson de Kremer R. Enzyme replacement therapy in late infantile neuronal ceroid lipofuscinosis: a 12-month follow-up study. Mol Genet Metab. 2018;123(2):S89.

clinical_trial2018
4

Macaulay SM, McKay RD, Hughes BP. Adult-onset neuronal ceroid lipofuscinosis: systematic review of global prevalence and phenotype. J Neurol. 2022;269(8):4251-4263.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Adult Neuronal Ceroid Lipofuscinosis C0022797. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy